Acne vulgaris: A disease of western civilization

Archives of Dermatology

Volumn 138, Issue 12, 2002, Pages 1584-1590

  Cordain, Loren ^a   Lindeberg, Staffan ^b   Hurtado, Magdalena ^c   Hill, Kim ^c   Eaton, S Boyd ^d   Brand Miller, Jennie ^e  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VULGARIS; ADULT; ARTICLE; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; INCIDENCE; MALE; PAPUA NEW GUINEA; PARAGUAY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ACNE VULGARIS; ADOLESCENT; ADULT; AGE DISTRIBUTION; DEVELOPING COUNTRIES; DIET; FEMALE; HUMANS; HYPERINSULINISM; INCIDENCE; MALE; PAPUA NEW GUINEA; PARAGUAY; POPULATION SURVEILLANCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 0036900817     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol. 1998;39(2, pt 3):S34-S37.
2. Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol. 1999;41:577-580.
3. Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. BMJ. 1979;1:1109-1110.
4. Rademaker M, Garioch JJ, Simpson NB. Acne in schoolchildren: No longer a concern for dermatoloigsts. BMJ. 1989;298:1217-1219.
5. Kilkenny M, Merlin K, Plunkett A, Marks R. The prevalence of common skin conditions in Australian school students, III: Acne vulgaris. Br J Dermatol. 1998;139:840-845.
6. Lello J, Pearl A, Arroll B, Yallop J, Birchall NM. Prevalence of acne vulgaris in Auckland senior high school students. N Z Med J. 1995;108:287-289.
7. Schaefer O. When the Eskimo comes to town. Nutr Today. 1971;6:8-16.
8. Steiner PE. Necropsies on Okinawans: Anatomic and pathologic observations. Arch Pathol. 1946;42:359-380.
9. Bechelli LM, Haddad N, Pimenta WP, et al. Epidemiological survey of skin diseases in schoolchildren living in the Purus Valley (Acre State, Amazonia, Brazil). Dermatologica. 1981;163:78-93.
10. Freyre EA, Rebaza RM, Sami DA, Lozada CP. The prevalence of facial acne in Peruvian adolescents and its relation to their ethnicity. J Adolesc Health. 1998;22:480-484.
11. Park RG. The age distribution of common skin disorders in the Bantu of Pretoria, Transvaal. Br J Dermatol. 1968;80:758-761.
12. Findlay GH. The age incidence of common skin diseases in the white population of the Transvaal. Br J Dermatol. 1967;79:538-542.
13. Cunliffe WJ, Cotterill JA. The acnes: Clinical features, pathogenesis and treatment. In: Rook A, ed. Major Problems in Dermatology. Philadelphia, Pa: WB Saunders Co; 1975:13-14.
14. Lindeberg S, Lundh B. Apparent absence of stroke and ischaemic heart disease in a traditional Melanesian island: A clinical study in Kitava. J Intern Med. 1993;233:269-275.
15. Lindeberg S, Nilsson-Ehle P, Terént A, Vessby B, Scherstén B. Cardiovascular risk factors in a Melanesian population apparently free from stroke and ischaemic heart disease: The Kitava Study. J Intern Med. 1994;236:331-340.
16. Lindeberg S, Eliasson M, Lindahl B, Ahrén B. Low serum insulin in traditional Pacific Islanders: The Kitava Study. Metabolism. 1999;48:1216-1219.
17. Lindeberg S, Berntorp E, Carlsson R, Eliasson M, Marckmann P. Haemostatic variables in Pacific Islanders apparently free from stroke and ischaemic heart disease. Thromb Haemost. 1997;77:94-98.
18. Lindeberg S, Soderberg S, Ahren B, Olsson T. Large differences in serum leptin levels between nonwesternized and westernized populations: The Kitava Study. J Intern Med. 2001;249:553-558.
19. Schiefenhövel W, Bell-Krannhals I. Wer teilt, hat teil an der macht: Systeme der yams-vergabe auf den Trobriand Inseln, Papua-Neuguinea. Mitt Anthropol Gesell Wien. 1986;116:19-39.
20. Hawkes K, Kaplan H, Hill K, Hurtado M. Aché at the settlement: Contrasts between farming and foraging. Hum Ecol. 1987;15:133-161.
21. Hurtado AM, Hill K, Kaplan H, Hurtado I. Tradeoffs between female food acquisition and child care among Hiwi and Aché foragers. Hum Nature. 1992;3:185-216.
22. Hill K, Hurtado AM. Aché Life History. The Ecology and Demography of a Foraging People. New York, NY: Aldine de Gruyter; 1996.
23. Gurven M, Allen-Arave W, Hill K, Hurtado AM. "It's a wonderful life": Signaling generosity among the Aché of Paraguay. Evol Hum Behav. 2000;21:263-282.
24. Hurtado AM, Hill KR, Rosenblatt W, Bender J, Scharmen T. A longitudinal study of tuberculosis outcomes among immunologically naïve Aché natives of Paraguay. Am J Phys Anthropol. In press.
25. McMillan G. Ache Residential Grouping and Social Foraging [dissertation]. Albuquerque: University of New Mexico; 2001.
26. Kaplan H, Hill K, Lancaster J, Hurtado AM. The evolution of intelligence and the human life history. Evol Anthropol. 2000;9:156-184.
27. Pochi PE, Shalita AR, Strauss JS, et al. Report of the Consensus Conference on Acne Classification: Washington, DC, March 24 and 25, 1990. J Am Acad Dermatol. 1991;24:495-500.
28. Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: A comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol. 1999;141:297-300.
29. Walton S, Wyat EH, Cunliffe WJ. Genetic control of sebum excretion and acne: A twin study. Br J Dermatol. 1989;121:144-145.
30. Fleischer AB, Feldman SR, Bradham DD. Office-based physician services provided by dermatologists in the United States in 1990. J Invest Dermatol. 1994;102:93-97.
31. Eichenfield LF, Leyden JJ. Acne: Current concepts of pathogenesis and approach to rational treatment. Pediatrician. 1991;18:218-223.
32. Thiboutot DM. Acne: An overview of clinical research findings. Adv Clin Res. 1997;15:97-109.
33. Webster GF. Acne vulgaris: State of the science. Arch Dermatol. 1999;135:1101-1102.
34. Green J, Sinclair RD. Perceptions of acne vulgaris in final-year medical student written examination answers. Australas J Dermatol. 2001;42:98-101.
35. Holt SA, Brand Miller JC, Petocz P. An insulin index of foods: The insulin demand generated by 100-kJ portions of common foods. Am J Clin Nutr. 1997;66:1264-1276.
36. Daly ME, Vale C, Walker M, Alberti KG, Mathers JC. Dietary carbohydrates and insulin sensitivity: A review of the evidence and clinical implications. Am J Clin Nutr. 1997;66:1072-1085.
37. Zammit VA, Waterman IJ, Topping D, McKay G. Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr. 2001;131:2074-2077.
38. Nam SY, Lee EJ, Kim KR, et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord. 1997;21:355-359.
39. Attia N, Tamborlane WV, Heptulla R, et al. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab. 1998;83:1467-1471.
40. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-1 in insulin-dependent diabetes. J Clin Endocrinol Metab. 1994;79:872-878.
41. Holly JMP. The physiological role of IGFBP-1. Acta Endocrinol. 1991;124:55-62.
42. Ferry RJ, Cerri RW, Cohen P. Insulin-like growth factor binding proteins: New proteins, new functions. Horm Res. 1999;51:53-67.
43. Rudman SM, Philpott MP, Thomas GA, Kealey T. The role of IGF-I in human skin and its appendages: Morphogen as well as mitogen? J Invest Dermatol. 1997;109:770-777.
44. Bol KK, Kiguchi K, Gimenez-Conti I, Rupp T, DiGiovanni J. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene. 1997;14:1725-1734.
45. Aizawa H, Niimura M. Elevated serum insulin-like growth factor-I (IGF-1) levels in women with postadolescent acne. J Dermatol. 1995;22:249-252.
46. Aizawa H, Niimura M. Mild insulin resistance during oral glucose tolerance test (OGTT) in women with acne. J Dermatol. 1996;23:526-529.
47. Liu VR. The Glycaemic Index and the Insulin-Like Growth Factor System [honors thesis]. Sydney, Australia: Human Nutrition Unit, Dept of Biochemistry, University of Sydney; 2000.
48. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol. 1995;9:361-367.
49. Vacaresse N, Lajoie-Mazenc I, Auge N, et al. Activation of epithelial growth factor receptor pathway by unsaturated fatty acids. Circ Res. 1999;85:892-899.
50. Schleicher ED, Weigert C. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int. 2000;58:13-18.
51. Edmondson SR, Murashita MM, Russo VC, Wraight CJ, Werther GA. Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFβ1. J Cell Physiol. 1999;179:201-207.
52. Evans TRJ, Kaye SB. Retinoids: Present role and future potential. Br J Cancer. 1999;80:1-8.
53. Yang Q, Mori I, Shan L, et al. Biallelic inactivation of retinoic acid receptor B2 gene by epigenetic change in breast cancer. Am J Pathol. 2001;158:299-303.
54. Liu B, Lee HY, Weinzimer SA, et al. Direct functional interaction between insulin-like growth factor-binding protein-3 and retionoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem. 2000;275:33607-33613.
55. Wendling O, Chambon P, Mark M. Retinoid X receptors are essential for early mouse development and placentogenesis. Proc Natl Acad Sci U S A. 1999;96:547-551.
56. Chiba H, Clifford J, Metzger D, Chamborn P. Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells. Mol Cell Biol. 1997;17:3013-3020.
57. Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol. 2000;18:1-9.
58. Thacher SM, Vasudevan J, Chandraratna RA. Therapeutic applications for ligands of retinoid receptors. Curr Pharm Des. 2000;6:25-58.
59. Barbieri RL, Smith S, Ryan KJ. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 1988;50:197-212.
60. Cara JF. Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm Res. 1994;42:49-54.
61. Bebakar WM, Honour JW, Foster D, Liu YL, Jacobs HS. Regulation of testicular function by insulin and transforming growth factor-beta. Steroids. 1990;55:266-270.
62. De Mellow JS, Handelsman DJ, Baxter RC. Short-term exposure to insulin-like growth factors stimulates testosterone production by testicular interstitial cells. Acta Endocrinol. 1987;115:483-489.
63. Crave JC, Lejeune H, Brebant C, Baret C, Pugeat M. Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells. J Clin Endocrinol Metab. 1995;80:1283-1289.
64. Singh A, Hamilton-Fairley D, Koistinen R, et al. Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J Endocrinol. 1990;124:R1-R3.
65. Pugeat M, Crave JC, Elmidani M, et al. Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin. J Steroid Biochem Mol Biol. 1991;40:841-849.
66. Vermeulen A, Kaufman JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab. 1996;81:1821-1826.
67. Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, et al. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab. 1996;81:2534-2540.
68. Erfurth EM, Hagmar LE, Saaf M, Hall K. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle aged men. Clin Endocrinol. 1996;44:659-664.
69. Zouboulis CC, Xia L, Akamatsu H, et al. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology. 1998;196:21-31.
70. Deplewski D, Rosenfield RL. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocnnology. 1999;140:4089-4094.
71. Klinger B, Anin S, Silbergeld A, Eshet R, Laron Z. Development of hyperandrogenism during treatment with insulin-like growth hormone factor-I (IGF-I) in female patients with Laron syndrome. Clin Endocrinol. 1998;48:81-87.
72. Thiboutot D, Gilliland K, Light J, Lookingbill D. Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol. 1999;135:1041-1045.
73. Falsetti L, Eleftheriou G. Hyperinsulinemia in the polycystic ovary syndrome: A clinical endocrine and echographic study in 240 patients. Gynecol Endocrinol. 1996;10:319-326.
74. Nestler JE. Insulin regulation of human ovarian androgens. Hum Reprod. 1997;12(suppl 1):53-62.
75. Thierry van Dessel HJ, Lee PD, Faessen G, Fauser BC, Giudice LC. Elevated serum levels of free insulin-like growth factor-I levels in polycystic ovary syndrome. J Clin Endocrinol Metab. 1999;84:3030-3035.
76. Pasquali R, Casimirri F, Vicennati V. Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome. Hum Reprod. 1997;12(suppl 1):82-87.
77. Ehrmann DA. Insulin-lowering therapeutic modalities for polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999;28:423-438.
78. Cohen JL, Cohen AD. Pustular acne, staphyloderma and its treatment with tolbutamide. CMAJ. 1959;80:629-632.
79. Bettley FR. The treatment of acne vulgaris with tolbutamide. Br J Dermatol. 1961;73:149-151.
80. Singh I, Gaind ML, Jayram D. Tolbutamide in the treatment of skin diseases. Br J Dermatol. 1961;73:362-366.
81. Daniel M, Rowley KG, McDermott R, Mylvaganam A, O'Dea K. Diabetes incidence in an Australian aboriginal population: An 8-year follow-up study. Diabetes Care. 1999;22:1993-1998.
82. Ebbesson SO, Schraer CD, Risica PM, et al. Diabetes and impaired glucose tolerance in three Alaskan Eskimo populations: The Alaska-Siberia Project. Diabetes Care. 1998;21:563-569.
83. Merimee TJ, Rimoin DL, Cavalli-Sforza LL. Metabolic studies in the African Pygmy. J Clin Invest. 1972;51:395-401.
84. O'Dea K. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian Aborigines after temporary reversion to traditional lifestyle. Diabetes. 1984;33:596-603.
85. Mouratoff GJ, Scott EM. Diabetes mellitus in Eskimos after a decade. JAMA. 1973;226:1345-1346.
86. Spielman RS, Fajans SS, Neel JV, Pek S, Floyd JC, Oliver WJ. Glucose tolerance in two unacculturated Indian tribes of Brazil. Diabetologia. 1982;23:90-93.
87. Salmeron J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care. 1997;20:545-550.
88. Frost G, Leeds A, Trew G, Margara R, Dornhorst A. Insulin sensitivity in women at risk of coronary heart disease and the effects of a low glycemic diet. Metabolism. 1998;47:1245-1251.
89. Berrino F, Bellati C, Secreto G, et al. Reducing bioavailable sex hormones through a comprehensive change in diet: The Diet and Androgens (DIANA) Randomized Trial. Cancer Epidemiol Biomarkers Prev. 2001;10:25-33.